The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Up to one third of individuals with NAFLD will develop nonalcoholic steatohepatitis (NASH), which is associated with progression to cirrhosis and is rapidly becoming the leading indication for liver transplantation. Sarcopenia is defined as a progressive and generalized loss of skeletal muscle mass, strength, and function. It is observed in up to 60% of patients with end‐stage liver disease and portends a poor prognosis. Recent studies have shown that sarcopenia is a novel risk factor for developing NAFLD. Pathophysiological mechanisms relating sarcopenia and NASH may include insulin resistance (IR) and increased inflammation. IR leads to accumulation of triglycerides in both muscle tissue and the liver. It also exacerbates proteolysis and leads to muscle depletion. Chronic inflammation leads to liver injury and progression of fibrosis. The inflammatory milieu also stimulates protein catabolism. Viewing skeletal muscle as an endocrine organ that secretes various salutary myokines may help us understand its role in the development of steatosis. A better understanding of the pathophysiology will aid in developing physical and pharmacological therapeutic interventions. In this review, we will explore the complex inter‐relationships between sarcopenia and NASH. We will discuss the impact of sarcopenia in patients with NASH and therapeutic options for the management of sarcopenia. (H epatology 2017;66:2055–2065)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600
RetractedSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102
Visser, M., Deeg, D. J. H., & Lips, P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030604 · Cited by 1,099
Volpi, E., Kobayashi, H., Sheffield-Moore, M., Mittendorfer, B., & Wolfe, R. R. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.2.250 · Cited by 846
Effects of Resistance Training on Older Adults
Hunter, G. R., McCarthy, J. P., & Bamman, M. M. (2004) · Sports Medicine · doi:10.2165/00007256-200434050-00005 · Cited by 764
Sarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608
Srikanthan, P., Hevener, A. L., & Karlamangla, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010805 · Cited by 600
Villareal, D. T., Apovian, C. M., Kushner, R. F., & Klein, S. (2005) · Obesity Research · doi:10.1038/oby.2005.228 · Cited by 579
Montano-Loza, A. J., Angulo, P., Meza-Junco, J., Prado, C. M. M., Sawyer, M. B., Beaumont, C., Esfandiari, N., Ma, M., & Baracos, V. E. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12039 · Cited by 512
A multicenter study to define sarcopenia in patients with end-stage liver disease
Carey, E. J., Lai, J. C., Wang, C. W., Dasarathy, S., Lobach, I., Montano‐Loza, A. J., Dunn, M. A., & for the Fitness, L. E. (2017) · Liver Transplantation · doi:10.1002/lt.24750 · Cited by 498
Stienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J. E. M., van Rooijen, N., Staels, B., Kersten, S., & Müller, M. (2010) · Hepatology · doi:10.1002/hep.23337 · Cited by 452
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
Koo, B. K., Kim, D., Joo, S. K., Kim, J. H., Chang, M. S., Kim, B. G., Lee, K. L., & Kim, W. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.019 · Cited by 440 · cited 5×
“Koo et al.((19)) Sarcopenia is an independent risk factor for non-”
BackgroundInfluentialKim, T. N., Yang, S. J., Yoo, H. J., Lim, K. I., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.130 · Cited by 401 · cited 1×
“Indeed, studies have shown that patients with sarcopenia have an increased body fat mass, more components of MetS, and higher CRP levels.((41)) Furthermore, studies have shown that sarcopenia and visceral obesity in the elderly may synergistically increase their effect on physical disability, metabolic disorders, and…”
BackgroundWeinheimer, E. M., Sands, L. P., & Campbell, W. W. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00298.x · Cited by 391
Sarcopenia impairs prognosis of patients with liver cirrhosis
Hanai, T., Shiraki, M., Nishimura, K., Ohnishi, S., Imai, K., Suetsugu, A., Takai, K., Shimizu, M., & Moriwaki, H. (2015) · Nutrition · doi:10.1016/j.nut.2014.07.005 · Cited by 390
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Hong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385 · cited 9×
“(56) Supplementation with BCAA has also been Hong et al.(42) Relationship between sarcopenia and non-alcoholic fatty liver disease: the Korean sarcopenic obesity study Cross-sectional study of 526 Korean adults (62% women) NAFLD was diagnosed using CT. LAI was used to define NAFLD.”
BackgroundInfluentialMyostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
Becker, C., Lord, S. R., Studenski, S. A., Warden, S. J., Fielding, R. A., Recknor, C. P., Hochberg, M. C., Ferrari, S. L., Blain, H., Binder, E. F., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00298-3 · Cited by 381
Identification of a Vitamin D response element in the human insulin receptor gene promoter
Maestro, B., Dávila, N., Carranza, M. C., & Calle, C. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00032-3 · Cited by 377
Singal, A. G., Manjunath, H., Yopp, A. C., Beg, M. S., Marrero, J. A., Gopal, P., & Waljee, A. K. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.476 · Cited by 362
Lee, Y.-H., Jung, K. S., Kim, S. U., Yoon, H.-J., Yun, Y. J., Lee, B.-W., Kang, E. S., Han, K.-H., Lee, H. C., & Cha, B.-S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.051 · Cited by 340
Lee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2016) · Hepatology · doi:10.1002/hep.28376 · Cited by 340
Sinclair, M., Gow, P. J., Grossmann, M., & Angus, P. W. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13549 · Cited by 316
Myostatin/activin pathway antagonism: molecular basis and therapeutic potential
Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314
Sarcopenic-obesity and cardiovascular disease risk in the elderly
Stephen, W. C., & Janssen, I. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0084-z · Cited by 301
Montano-Loza, A. J., Meza-Junco, J., Baracos, V. E., Prado, C. M. M., Ma, M., Meeberg, G., Beaumont, C., Tandon, P., Esfandiari, N., Sawyer, M. B., et al. (2014) · Liver Transplantation · doi:10.1002/lt.23863 · Cited by 297
Hondares, E., Rosell, M., Díaz-Delfín, J., Olmos, Y., Monsalve, M., Iglesias, R., Villarroya, F., & Giralt, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252775 · Cited by 295
Six-minute walk distance predicts mortality in liver transplant candidates
Carey, E. J., Steidley, E. D., Aqel, B. A., Byrne, T. J., Mekeel, K. L., Rakela, J., Vargas, H. E., & Douglas, D. D. (2010) · Liver Transplantation · doi:10.1002/lt.22167 · Cited by 293
Phillips, T., & Leeuwenburgh, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2870fje · Cited by 283
Meta-analysis: vitamin D and non-alcoholic fatty liver disease
Eliades, M., Spyrou, E., Agrawal, N., Lazo, M., Brancati, F. L., Potter, J. J., Koteish, A. A., Clark, J. M., Guallar, E., & Hernaez, R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12377 · Cited by 273
Sinclair, M., Grossmann, M., Hoermann, R., Angus, P. W., & Gow, P. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.007 · Cited by 269
A Model to Identify Sarcopenia in Patients With Cirrhosis
Tandon, P., Low, G., Mourtzakis, M., Zenith, L., Myers, R. P., Abraldes, J. G., Shaheen, A. A. M., Qamar, H., Mansoor, N., Carbonneau, M., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.04.040 · Cited by 249
Insulin resistance: a contributing factor to age-related muscle mass loss?
Guillet, C., & Boirie, Y. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(05)73648-x · Cited by 236
Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
Zhang, H.-J., Zhang, X.-F., Ma, Z.-M., Pan, L.-L., Chen, Z., Han, H.-W., Han, C.-K., Zhuang, X.-J., Lu, Y., Li, X.-J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.030 · Cited by 234
Barchetta, I., Carotti, S., Labbadia, G., Gentilucci, U. V., Muda, A. O., Angelico, F., Silecchia, G., Leonetti, F., Fraioli, A., Picardi, A., et al. (2012) · Hepatology · doi:10.1002/hep.25930 · Cited by 229
Yilmaz, Y. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12046 · Cited by 218
Dunlop, T. W., Väisänen, S., Frank, C., Molnár, F., Sinkkonen, L., & Carlberg, C. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.060 · Cited by 217
Petta, S., Ciminnisi, S., Di Marco, V., Cabibi, D., Cammà, C., Licata, A., Marchesini, G., & Craxì, A. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13889 · Cited by 215
Román, E., Torrades, M. T., Nadal, M. J., Cárdenas, G., Nieto, J. C., Vidal, S., Bascuñana, H., Juárez, C., Guarner, C., Córdoba, J., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3086-6 · Cited by 197
Intermuscular adipose tissue is muscle specific and associated with poor functional performance
Tuttle, L. J., Sinacore, D. R., & Mueller, M. J. (2012) · Journal of Aging Research · doi:10.1155/2012/172957 · Cited by 193
Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation
Tsien, C., Garber, A., Narayanan, A., Shah, S. N., Barnes, D., Eghtesad, B., Fung, J., McCullough, A. J., & Dasarathy, S. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12524 · Cited by 179
Giusto, M., Lattanzi, B., Albanese, C., Galtieri, A., Farcomeni, A., Giannelli, V., Lucidi, C., Di Martino, M., Catalano, C., & Merli, M. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000274 · Cited by 173
Miller, A. M., Wang, H., Bertola, A., Park, O., Horiguchi, N., Ki, S. H., Yin, S., Lafdil, F., & Gao, B. (2011) · Hepatology · doi:10.1002/hep.24517 · Cited by 162
Nutrition Assessment and Management in Advanced Liver Disease
Johnson, T., Overgard, E. B., Cohen, A. E., & DiBaise, J. K. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533612469027 · Cited by 160
Román, E. M., García-Galcerán, C., Torrades, M. T., Herrera, S., Marín, A., Doñate, M., Alvarado‐Tápias, E., Malouf, J., Nácher, L., Serra-Grima, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151652 · Cited by 159
Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M., & Kambadur, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2079-7 · Cited by 158 · cited 9×
“Furthermore, those with sarcopenia were more likely to have fibrosis when compared to their counterparts; this association was independent of obesity and IR.”
BackgroundInfluentialRiachy, R., Vandewalle, B., Kerr-Conte, J., Moerman, E., Sacchetti, P., Lukowiak, B., Gmyr, V., Bouckenooghe, T., Dubois, M., & Pattou, F. N. (2002) · Endocrinology · doi:10.1210/en.2002-220449 · Cited by 147
Carias, S., Castellanos, A. L., Vilchez, V., Nair, R. T., Cruz, A. C. D., Watkins, J., Barrett, T. A., Patel, T., Esser, K. A., & Gedaly, R. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13166 · Cited by 133
Yanai, H. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2361w · Cited by 120
Han, S., & Chiang, J. Y. L. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025155 · Cited by 108
Elevated Myostatin Levels in Patients with Liver Disease
García, P. S., Cabbabe, A., Kambadur, R., Nicholas, G., & CSETE, M. E. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181eac1c9 · Cited by 107
Gloth, F. M., Smith, C. E., Hollis, B. W., & Tobin, J. D. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb07404.x · Cited by 103
Eley, H. L., Russell, S. T., & Tisdale, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90530.2008 · Cited by 100
Low testosterone levels as an independent predictor of mortality in men with chronic liver disease
Grossmann, M., Hoermann, R., Gani, L. U., Chan, I., Cheung, A. S., Gow, P. J., Li, A., Zajac, J. D., & Angus, P. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04347.x · Cited by 97
Matsumoto, R., Fukuoka, H., Iguchi, G., Nishizawa, H., Bando, H., Suda, K., Takahashi, M., & Takahashi, Y. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.07.002 · Cited by 82
Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease
Domínguez, V. M., González-Casas, R., Jiménez-Ridruejo, J. M., García-Buey, L., & Moreno‐Otero, R. (2013) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082013000700006 · Cited by 79
Vitamin D Deficiency, hypocalcemia, and increased skeletal muscle degradation in rats.
Wassner, S. J., Li, J. B., Sperduto, A., & Norman, M. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110947 · Cited by 74
Fuller, J. C., Baier, S. M., Flakoll, P. J., Nissen, S., Abumrad, N. N., & Rathmacher, J. A. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111413903 · Cited by 73
Bhanji, R. A., Carey, E. J., Yang, L., & Watt, K. D. S. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.004 · Cited by 70
Self-citationGrowth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction
Assy, N., Pruzansky, Y., Gaitini, D. E., Orr, Z. S., Hochberg, Z., & Baruch, Y. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.013 · Cited by 69
Development of imaging methods to assess adiposity and metabolism
Heymsfield, S. B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.242 · Cited by 67
Wilson, J. M., Grant, S. C., Lee, S.-R., Masad, I. S., Park, Y.-M., Henning, P. C., Stout, J. R., Loenneke, J. P., Arjmandi, B. H., Panton, L. B., et al. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-18 · Cited by 58
Exercise in End-Stage Renal Disease
Segura‐Ortí, E., & Johansen, K. L. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00766.x · Cited by 54
Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?
Merli, M., & Dasarathy, S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.014 · Cited by 53
Presence of Sarcopenia (Muscle Wasting) in Patients With Nonalcoholic Steatohepatitis
Issa, D., Alkhouri, N., Tsien, C., Shah, S., Lopez, R., McCullough, A., & Dasarathy, S. (2014) · Hepatology · doi:10.1002/hep.26908 · Cited by 46
Liver transplantation arrests and reverses muscle wasting
Bergerson, J. T., Lee, J., Furlan, A., Sourianarayanane, A., Fetzer, D. T., Tevar, A. D., Landsittel, D. P., DiMartini, A. F., & Dunn, M. A. (2015) · Clinical Transplantation · doi:10.1111/ctr.12506 · Cited by 43
Perkisas, S., Cock, A. D., Verhoeven, V., & Vandewoude, M. F. J. (2017) · Geriatrics · doi:10.3390/geriatrics2010011 · Cited by 43
Dasarathy, S. (2014) · Hepatology · doi:10.1002/hep.27134 · Cited by 32
Pang, Q., Qu, K., Liu, C., Zhang, J., & Liu, S. (2015) · Hepatology · doi:10.1002/hep.28010 · Cited by 15
Stockdale, A., Webb, N. A., Wootton, J., Drennan, J., Brown, S., & Stokes, M. J. (2017) · Geriatrics · doi:10.3390/geriatrics2010012 · Cited by 11
Cited by
Lonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T. A., Abdelmalek, M. F., & Suzuki, A. (2019) · Hepatology · doi:10.1002/hep.30626 · Cited by 1,050
Lai, J. C., Tandon, P., Bernal, W., Tapper, E. B., Ekong, U., Dasarathy, S., & Carey, E. J. (2021) · Hepatology · doi:10.1002/hep.32049 · Cited by 742
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Wu, X., Li, X., Xu, M., Zhang, Z., He, L., & Li, Y. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247617 · Cited by 310
Younes, R., & Bugianesi, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1677517 · Cited by 235
Metadata
- Authors
- Bhanji, R. A., Narayanan, P., Allen, A. M., Malhi, H., & Watt, K. D.
- Venue
- Hepatology
- Published
- 2017-10-30
- Volume
- 66
- Issue
- 6
- Pages
- 2055-2065
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2743916466
- Cited by
- 258
- References
- 75
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.